Details

Draft guidance document: Identifying and labelling medicinal ingredients in new drug products - Canada.ca

Metadata and links for an archived snapshot.

Source: Health Canada
Date: Mar 2, 2026 · edition #6
Timestamp: 2026-03-02T23:30:16.932Z
Language: en
Original URL: https://www.canada.ca/en/health-canada/services/drugs-health-products/public-involvement-consultations/drug-products/consultation-profile-draft-generic-drug-equivalence/document-2.html
Replay URL: https://replay.healtharchive.ca/job-6/20260302233016/https://www.canada.ca/en/health-canada/services/drugs-health-products/public-involvement-consultations/drug-products/consultation-profile-draft-generic-drug-equivalence/document-2.html#ha_snapshot=616722
ID: 616722
Status: 200
Type: text/html

Independent archive · Not an official government website. For up-to-date recommendations, always consult the official source website.

Other snapshots